Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice

Biochemical and Biophysical Research Communications

Volumn 409, Issue 2, 2011, Pages 177-180

  Adachi, Hironori ^a   Kondo, Tatsuya ^a   Koh, Gou Young ^b   Nagy, Andras ^c   Oike, Yuichi ^a   Araki, Eiichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Angptl4; Diabetes mellitus; Familial hypercholesterolemia; Lipoprotein lipase; Postprandial hypertriglyceridemia

Indexed keywords

ANGIOPOIETIN LIKE PROTEIN FAMILY 4; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; REGULATOR PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; DRUG TARGETING; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; GENE SILENCING; HYPERTRIGLYCERIDEMIA; INSULIN DEFICIENCY; KNOCKOUT MOUSE; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ANGIOPOIETINS; ANIMALS; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; FASTING; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, LDL; TRIGLYCERIDES;

MUS;

EID: 79957895547     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.110     Document Type: Article

References (17)

1. Taskinen M.R. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003, 46:733-749.
2. Kolovou G.D., Kostakou P.M., Anagnostopoulou K.K. Familial hypercholesterolemia and triglyceride metabolism. Int. J. Cardiol. 2011, 147:349-358.
3. Bagdade J.D., Porte D., Bierman E.L. Diabetic lipemia. A form of acquired fat-induced lipemia. N. Engl. J. Med. 1967, 276:427-433.
4. Eckel R.H., Yost T.J. Weight reduction increases adipose tissue lipoprotein lipase responsiveness in obese women. J. Clin. Invest. 1987, 80:992-997.
5. Oike Y., Akao M., Yasunaga K., Yamauchi T., Morisada T., Ito Y., Urano T., Kimura Y., Kubota Y., Maekawa H., Miyamoto T., Miyata K., Matsumoto S., Sakai J., Nakagata N., Takeya M., Koseki H., Ogawa Y., Kadowaki T., Suda T. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat. Med. 2005, 11:400-408.
6. Ge H., Yang G., Huang L., Motola D.L., Pourbahrami T., Li C. Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J. Biol. Chem. 2004, 279:2038-2045.
7. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 2004, 101:15718-15723.
8. Desai U., Lee E.C., Chung K., Gao C., Gay J., Key B., Hansen G., Machajewski D., Platt K.A., Sands A.T., Schneider M., Van Sligtenhorst I., Suwanichkul A., Vogel P., Wilganowski N., Wingert J., Zambrowicz B.P., Landes G., Powell D.R. Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. Proc. Natl. Acad. Sci. USA 2007, 104:11766-11771.
9. Koster A., Chao Y.B., Mosior M., Ford A., Gonzalez-DeWhitt P.A., Hale J.E., Li D., Qiu Y., Fraser C.C., Yang D.D., Heuer J.G., Jaskunas S.R., Eacho P. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 2005, 146:4943-4950.
10. Sukonina V., Lookene A., Olivecrona T., Olivecrona G. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl. Acad. Sci. USA 2006, 103:17450-17455.
11. Adachi H., Fujiwara Y., Kondo T., Nishikawa T., Ogawa R., Matsumura T., Ishii N., Nagai R., Miyata K., Tabata M., Motoshima H., Furukawa N., Tsuruzoe K., Kawashima J., Takeya M., Yamashita S., Koh G.Y., Nagy A., Suda T., Oike Y., Araki E. Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis. Biochem. Biophys. Res. Commun. 2009, 379:806-811.
12. Tavangar K., Murata Y., Pedersen M.E., Goers J.F., Hoffman A.R., Kraemer F.B. Regulation of lipoprotein lipase in the diabetic rat. J. Clin. Invest. 1992, 90:1672-1678.
13. Watts G.F. Postprandial lipaemia in familial hypercholesterolaemia: clinical and metabolic significance. Atherosclerosis 2000, 148:426-428.
14. Dane-Stewart C.A., Watts G.F., Mamo J.C., Dimmitt S.B., Barrett P.H., Redgrave T.G. Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia. Eur. J. Clin. Invest. 2001, 31:113-117.
15. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 1993, 92:883-893.
16. Rumsey S.C., Obunike J.C., Arad Y., Deckelbaum R.J., Goldberg I.J. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J. Clin. Invest. 1992, 90:1504-1512.
17. Ohno T., Horio F., Tanaka S., Terada M., Namikawa T., Kitoh J. Fatty liver and hyperlipidemia in IDDM (insulin-dependent diabetes mellitus) of streptozotocin-treated shrews. Life Sci. 2000, 66:125-131.